Botanix Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Botanix Pharmaceuticals is dedicated to improving the lives of patients with skin diseases such as acne, psoriasis, and atopic dermatitis. The company aims to provide new treatment options for these conditions, which are currently not effectively addressed or have side effects from existing therapies. Botanix is exploring the potential of synthetic cannabidiol, a pharmaceutical ingredient being researched for various medical uses, including epilepsy, pain, arthritis, and schizophrenia. The company is now getting ready to conduct human trials using synthetic cannabidiol in their unique drug delivery system, PermetrexTM, for direct application to the skin.
Botanix Pharmaceuticals has raised $20.2M across 1 funding round on record, the most recent an undisclosed round of $20.2M announced in Jun 2025.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Botanix Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Botanix Pharmaceuticals Funding Rounds
Botanix Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Botanix Pharmaceuticals Funding Compared to Other Health Care Startups
Botanix Pharmaceuticals' latest round of $20.2M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Botanix Pharmaceuticals in Health Care and Perth
Companies Similar to Botanix Pharmaceuticals
Navi Medical Technologies is a company that specializes in the development of medical devices.
Adherium (previously known as Nexus6) is a privately owned developer and manufacturer of solutions that help…
Everlab is an Australian health-tech company building the infrastructure for preventative health
Sonder is the trusted wellbeing partner for some of the world’s most innovative organisations as they…
EMVision Medical is developing a portable brain scanner for rapid, point of care, stroke diagnosis and…
Gelteq is a biotechnology company specializing in the formulation, development, and manufacturing of…
Mixed Martial Arts Group is a company that specializes in technology and concentrates on the worldwide combat…
4DMedical (formerly known as 4Dx) is a global medical technology company aiming to change the outcome for…
Splose is delightful software for Allied Health Practitioners & NDIS Providers - The smarter way to support…
GenAqua Australia develops point-of-use water disinfection technology using high-strength UVC LED light to…
In 2013, Saluda Medical was founded with the objective of transforming four years of investigation from…
iiShield's goal is to enhance patient results and surgeon education in transplant surgery through the…
Botanix Pharmaceuticals Funding FAQs
What does Botanix Pharmaceuticals do?
Botanix Pharmaceuticals is dedicated to improving the lives of patients with skin diseases such as acne, psoriasis, and atopic dermatitis. The company aims to provide new treatment options for these conditions, which are currently not effectively addressed or have side effects from existing therapies. Botanix is exploring the potential of synthetic cannabidiol, a pharmaceutical ingredient being researched for various medical uses, including epilepsy, pain, arthritis, and schizophrenia. The company is now getting ready to conduct human trials using synthetic cannabidiol in their unique drug delivery system, PermetrexTM, for direct application to the skin.
How much funding has Botanix Pharmaceuticals raised?
Botanix Pharmaceuticals has raised $20.2M across 1 round on record. The most recent is an undisclosed round of $20.2M announced in Jun 2025.
When did Botanix Pharmaceuticals last raise funding?
Botanix Pharmaceuticals' most recent funding round on record is an undisclosed round of $20.2M, announced in Jun 2025.
Who founded Botanix Pharmaceuticals?
FundedIQ lists Roger New (Founder) at Botanix Pharmaceuticals.
Where is Botanix Pharmaceuticals headquartered?
Botanix Pharmaceuticals is based in Perth, Western Australia, Australia.
How many employees does Botanix Pharmaceuticals have?
Botanix Pharmaceuticals is in the 51-100 employee band.
How does Botanix Pharmaceuticals' funding compare to other Health Care startups?
Botanix Pharmaceuticals' latest round of $20.2M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Botanix Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Botanix Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.